About Tagra biotechnologies

Tagra Biotechnologies, established in 1998 and headquartered in Israel, specializes in delivering innovative delivery systems for active ingredients in the cosmetics industry. Tagra Biotechnologies is renowned for its microencapsulation technology which enhances the stability and efficacy of cosmetic formulations. Tagra Biotechnologies has revolutionized the cosmetics industry with its patented RND™ (Release on Demand) microencapsulation technology, which protects active ingredients until needed, improving product effectiveness and shelf life. This innovation also enhances the performance of ingredients like vitamins, sunscreens, organic oils, and anti-aging compounds, while enabling unique textures and visual effects.